CYTHW

Cyclo Therapeutics, Inc.

Healthcare · USD

Set alert

Price alert · CYTHW

All alert types
0.03 USD 0.00 0.00%
As of Mar 25, 2025
0.032 Day range 0.032
0.025 52-week range 0.614
YTD
0.00%
1 year
0.00%
Open
0.0697
Prev close
0.032
Mkt cap
928.01K
Vol
28.41K
Avg vol
12.32K
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
0.032
High
0.032
Forward P/E
0.00
Beta
-0.38
Short ratio
0.00
Inst. own
0.00%
Dividend
0.00
Ex-div date
50-d avg
0.1639
200-d avg
0.19289
1y target
0.00

2Y chart

Chart tools
Interval

Chart is warming up

The two-year price history for CYTHW has not been loaded yet. Try again in a moment.

Key statistics

Market cap
0
Enterprise value
0
Trailing P/E
0.00
Forward P/E
0.00
PEG ratio
0.00
Price / sales
0.00
Price / book
0.75
EPS (TTM)
0.00
Beta
-0.38
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
1.13M
Revenue growth
5.10%
Free cash flow
-10.79M
Total cash
1.12M
Total debt
3.00M
Return on equity
0.00%
Shares outstanding
0
Short % of float
0.00%
50-day average
0.1639
200-day average
0.19289

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

About Cyclo Therapeutics, Inc.

Cyclo Therapeutics, Inc., a clinical stage biotechnology company, engages in the development of cyclodextrin-based products for the treatment of neurodegenerative diseases. The company's lead drug candidate is Trappsol Cyclo (hydroxypropyl beta cyclodextrin), an orphan drug, which is in Phase III clinical trials for the treatment of Niemann-Pick Type C disease; and in Phase IIb clinical trials for the treatment of Alzheimer's disease. It also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. The company was formerly known as CTD Holdings, Inc. and changed its name to Cyclo Therapeutics, Inc. in September 2019. Cyclo Therapeutics, Inc. was incorporated in 1990 and is headquartered in Gainesville, Florida.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
United States

News

No recent headlines

Headlines appear here as they are published.

Your note

Sign in to keep a note on CYTHW — it syncs with the Stock Master app.

Institution ownership

CYTHW institution ownership
Holder% heldSharesValueReported
Citadel Advisors Llc0.50%11,5931.45KSep 29, 2024
Bank of America Corporation0.01%14417Sep 29, 2024